Selling stockholders can now immediately sell into the market, creating heavy supply overhang. Expect downward price pressure as the market absorbs potential sales. Monitor volume spikes and any subsequent 8-Ks for actual sales or further financing needs.
Price Chart
Executive Summary
AIM ImmunoTech's S-1 registration statement (File No. 333-296588) became effective on June 16, 2026, allowing selling stockholders to immediately resell up to 31,287,933 shares of common stock underlying warrants from prior transactions. The company receives no proceeds from this resale, and the potential dilution is massive relative to AIM's ~$10M market cap (stock at $0.52). This creates immediate overhang and selling pressure.
Key Facts
- SEC declared S-1 effective on June 16, 2026 (File No. 333-296588).
- Up to 31,287,933 shares registered for resale by selling stockholders — more than the estimated 19.2M shares outstanding.
- Shares include 14,903,840 from Class H Warrants, 15,038,702 from Class I Warrants, and placement agent warrants.
- AIM receives no proceeds from this resale registration.
- Last reported stock price on June 5, 2026 was $0.52 per share; market cap ~$10M.
Financial Impact
Potential dilution of over 160% of current shares outstanding, with no capital inflow to the company.
Risk Factors
- Massive dilution from warrant share resales could crush stock price.
- Company has no control over timing or volume of selling stockholder sales.
- Low liquidity and small market cap amplify price impact of any selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002022 |
| Document: 9999999995-26-002022-index.html | 9999999995-26-002022 |
| Document: 9999999995-26-002022.txt | 9999999995-26-002022 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 25d ago | DEF 14A | $0.1877 | awaiting T+20 | — | $0.1600 (−14.76%) |
Sep 22, 2026 4w ago | Press Release | $0.2156 $0.1662 | ▼ −22.91% | ▼ −22.35% | $0.1600 (−25.79%) |
Sep 14, 2026 5w ago | 8-K | $0.2100 | awaiting T+20 | — | $0.1600 (+23.81%) |
Aug 11, 2026 10w ago | 8-K | $0.2500 $0.2332 | ▼ −6.72% | ▼ −5.66% | $0.1600 (−36.00%) |
Aug 10, 2026 10w ago | 8-K | $0.2630 | awaiting T+20 | — | $0.1600 (+39.16%) |
Aug 10, 2026 10w ago | Press Release | $0.2630 | awaiting T+20 | — | $0.1600 (+39.16%) |
Aug 5, 2026 11w ago | 8-K | $0.2800 $0.2346 | ▼ −16.21% | ▼ −15.61% | $0.1600 (−42.86%) |
Aug 3, 2026 11w ago | Press Release | $0.2600 $0.2260 | ▼ −13.08% | ▼ −14.31% | $0.1600 (−38.46%) |
Jun 24, 2026 17w ago | EFFECT | $0.3740 $0.2534 | ▲ +32.25% | ▲ +34.18% | $0.1600 (+57.22%) |
Jun 18, 2026 18w ago | S-1 | $0.3799 $0.2730 | ▲ +28.14% | ▲ +28.67% | $0.1600 (+57.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers